• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Who gets renal bone disease before beginning dialysis?哪些人在开始透析前会患上肾性骨病?
Br Med J (Clin Res Ed). 1985 Jan 26;290(6464):271-5. doi: 10.1136/bmj.290.6464.271.
2
Letter: Aetiology of chronic renal failure and renal osteodystrophy.信件:慢性肾衰竭与肾性骨营养不良的病因
Br Med J. 1975 Mar 15;1(5958):628. doi: 10.1136/bmj.1.5958.628-b.
3
Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.尚未接受透析的终末期肾衰竭患者的肾性骨病谱
Nephrol Dial Transplant. 2003 Jun;18(6):1159-66. doi: 10.1093/ndt/gfg116.
4
Osteomalacia in patients with chronic renal failure before dialysis or transplantation.
Q J Med. 1983 Summer;52(207):332-48.
5
[Effect of the treatment of patients with chronic kidney failure on nephrogenic osteodystrophy].[慢性肾衰竭患者治疗对肾性骨营养不良的影响]
Klin Med (Mosk). 1984 Jun;62(6):40-4.
6
[X-ray features of fibrous osteodystrophy and osteomalacia in patients with chronic renal insufficiency under present-day treatment].
Ter Arkh. 1987;59(8):103-7.
7
Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.透析性骨软化症与铝中毒:一种肾性骨营养不良的形式。
ANNA J. 1985 Jun;12(3):189-91.
8
[The course of osteodystrophy in patients with chronic kidney failure on hemodialysis].[接受血液透析的慢性肾衰竭患者骨营养不良的病程]
Urol Nefrol (Mosk). 1993 Nov-Dec(6):51-4.
9
Letter: Aetiology of chronic renal failure and renal osteodystrophy.信函:慢性肾衰竭与肾性骨营养不良的病因学
Br Med J. 1975 Jun 14;2(5971):616. doi: 10.1136/bmj.2.5971.616-b.
10
Renal osteodystrophy.
Orthop Clin North Am. 1972 Nov;3(3):681-98.

引用本文的文献

1
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.西那卡塞在接受透析的继发性甲状旁腺功能亢进儿科受试者中的研究。
Pediatr Nephrol. 2020 Sep;35(9):1679-1697. doi: 10.1007/s00467-020-04516-4. Epub 2020 May 4.
2
The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis.拟钙剂KRN 1493可降低接受血液透析的慢性肾衰竭患者在血液透析当天和非血液透析当天的血浆甲状旁腺激素及离子钙浓度。
Br J Clin Pharmacol. 2004 Jun;57(6):726-34. doi: 10.1111/j.1365-2125.2004.02088.x.
3
CYP2D6, GST-M1 and GST-T1 enzymes: expression in parathyroid gland and association with the parathyroid hormone concentration during early renal replacement therapy.细胞色素P450 2D6、谷胱甘肽S-转移酶M1和谷胱甘肽S-转移酶T1酶:在甲状旁腺中的表达以及与早期肾脏替代治疗期间甲状旁腺激素浓度的关联
Br J Clin Pharmacol. 2003 Jul;56(1):68-77. doi: 10.1046/j.1365-2125.2003.01832.x.
4
Vitamin D and analogues in renal bone disease and implications for osteoporosis.
Osteoporos Int. 1997;7 Suppl 3:S179-83. doi: 10.1007/BF03194368.
5
Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.阿法骨化醇对轻至中度肾衰竭患者肾性骨病自然病程的影响。
BMJ. 1995 Feb 11;310(6976):358-63. doi: 10.1136/bmj.310.6976.358.
6
Hyperparathyroid bone disease in chronic renal failure.慢性肾衰竭中的甲状旁腺功能亢进性骨病
Ulster Med J. 1985 Aug;54 Suppl(Suppl):S34-43.

本文引用的文献

1
Vitamin D metabolites and their relationship to azotaemic osteodystrophy.维生素D代谢产物及其与氮质血症性骨营养不良的关系。
Clin Endocrinol (Oxf). 1980 Oct;13(4):375-85. doi: 10.1111/j.1365-2265.1980.tb03399.x.
2
Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis.
N Engl J Med. 1982 Jul 22;307(4):217-21. doi: 10.1056/NEJM198207223070403.
3
Plasma concentrations of vitamin D metabolites in puberty: effect of sexual maturation and implications for growth.青春期血浆维生素D代谢产物浓度:性成熟的影响及其对生长的意义。
J Clin Endocrinol Metab. 1982 Jul;55(1):94-101. doi: 10.1210/jcem-55-1-94.
4
The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.肾性骨营养不良中骨铝沉积的患病率及其与骨化三醇治疗反应的关系。
N Engl J Med. 1982 Sep 16;307(12):709-13. doi: 10.1056/NEJM198209163071202.
5
Effects of vitamin D metabolites and analogues on renal function.
Nephron. 1981;28(1):17-25. doi: 10.1159/000182088.
6
Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.接受维持性血液透析的无症状甲状旁腺功能亢进患者口服1,25-二羟基维生素D3与安慰剂的双盲试验。
Br Med J (Clin Res Ed). 1981 Jun 13;282(6280):1919-24. doi: 10.1136/bmj.282.6280.1919.
7
Osteomalacia in patients with chronic renal failure before dialysis or transplantation.
Q J Med. 1983 Summer;52(207):332-48.
8
The influence of age and sex on bone resorption of secondary hyperparathyroidism in renal osteodystrophy.
Calcif Tissue Int. 1984 Jan;36(1):25-30. doi: 10.1007/BF02405290.
9
Metabolic heterogeneity of the nephron.肾单位的代谢异质性
Miner Electrolyte Metab. 1982;7(5):225-36.
10
Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.常规剂量的1,25 - 二羟维生素D3无法治愈维生素D缺乏性佝偻病并抑制继发性甲状旁腺功能亢进。
Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):883-5. doi: 10.1136/bmj.284.6319.883.

哪些人在开始透析前会患上肾性骨病?

Who gets renal bone disease before beginning dialysis?

作者信息

Cundy T, Hand D J, Oliver D O, Woods C G, Wright F W, Kanis J A

出版信息

Br Med J (Clin Res Ed). 1985 Jan 26;290(6464):271-5. doi: 10.1136/bmj.290.6464.271.

DOI:10.1136/bmj.290.6464.271
PMID:3917782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1417569/
Abstract

To identify patients at risk from renal bone disease we compared the demographic characteristics of 243 patients with end stage renal failure grouped according to the presence (97 (40%] or absence of severe renal bone disease as judged by histological criteria. Youth, female sex, tubulointerstitial types of nephropathy, and a long duration of uraemia were all identified as significant independent risk factors for the development of bone disease. The relative risks from being female and having tubulointerstitial renal disease were separately identifiable when the estimated observation of renal failure was short (less than four years). The identification of patients at high risk from bone disease may clarify the pathogenesis and treatment strategies of renal osteodystrophy.

摘要

为了识别有患肾性骨病风险的患者,我们比较了243例终末期肾衰竭患者的人口统计学特征,这些患者根据组织学标准判断是否存在(97例[40%])严重肾性骨病进行分组。年轻、女性、肾小管间质类型的肾病以及长期尿毒症均被确定为骨病发生的显著独立危险因素。当肾衰竭的估计观察期较短(少于四年)时,女性和患有肾小管间质肾病的相对风险可分别识别。识别有高骨病风险的患者可能会阐明肾性骨营养不良的发病机制和治疗策略。